MARCI HAGEMAN: Open Payments
NPI 1861071532 · BUCKEYE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$334 in 5 payments from 4 companies in 2025. Trend: 2023 $213 · 2024 $234 · 2025 $334
Food & beverage: $334
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 1 | $130 |
| GENZYME CORPORATION | 1 | $92 |
| Alexion Pharmaceuticals, Inc. | 2 | $58 |
| AngioDynamics, Inc. | 1 | $53 |
Products named: Gamunex-C, FABRAZYME, ULTOMIRIS, VENACURE 1470 PRO.
Industry payments across AZ — which companies pay providers there.
